H 89 2HCl: Selective PKA Inhibition for cAMP Pathway Researc
2026-04-19
H 89 2HCl is a potent, selective protein kinase A inhibitor used to dissect cAMP/PKA signaling with high specificity. Its nanomolar affinity and distinct selectivity profile make it a key tool for studying protein phosphorylation and neurite outgrowth modulation across diverse biological models.
IGF2BP1-Mediated Macrophage Metabolism Drives Pulmonary Fibr
2026-04-18
The referenced study details how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, thereby enhancing macrophage glycolysis and M2 polarization. This work uncovers a novel IGF2BP1/THBS1/TLR4 regulatory axis, advancing mechanistic understanding of macrophage-driven fibrotic pathology and offering potential therapeutic targets.
Optimizing hiPSC-Derived Platelet Production via Small Molec
2026-04-17
This study presents a systematically optimized protocol for ex vivo platelet generation from human induced pluripotent stem cells (hiPSCs), significantly increasing yield and reducing costs via small molecule modulation. The approach demonstrates improved differentiation speed, functional platelet output, and practical potential for scalable cell therapy applications.
PPT (Propyl Pyrazole Triol): Precision ERα Agonist in Cancer
2026-04-16
PPT (Propyl Pyrazole Triol) empowers researchers to dissect estrogen receptor alpha signaling with unmatched selectivity, streamlining workflows in cancer and endocrine biology. This guide translates cutting-edge biomarker insights and experimental best practices into actionable protocols, ensuring reliable, high-fidelity results with APExBIO’s gold-standard ERα agonist.
ATS-9R: Adipocyte-Targeted Gene Delivery via Prohibitin Bind
2026-04-15
ATS-9R (Adipocyte-targeting sequence-9-arginine) is a non-viral gene delivery peptide that enables selective, efficient nucleic acid delivery to white adipose tissue through Prohibitin-mediated endocytosis. Its robust gene silencing capability, low cytotoxicity, and precise targeting make it a validated tool for obesity and metabolic disease research.
Novobiocin: Applied Protocols for Antimicrobial & Antiviral
2026-04-14
Novobiocin, a dual-action aminocoumarin antibiotic, enables researchers to tackle bacterial resistance, explore antiparasitic and antiviral strategies, and optimize apoptosis assays with data-driven precision. This article delivers stepwise workflows, troubleshooting guidance, and integrates new findings from SFTSV research for translational impact.
Pexmetinib (ARRY-614): Enhancing Cytokine Assays & Inflammat
2026-04-13
Pexmetinib (ARRY-614) empowers researchers with dual kinase inhibition for precise modulation of cytokine synthesis, validated in both cellular and translational models. Learn how APExBIO’s inhibitor optimizes workflows, advances myelodysplastic syndromes research, and incorporates the latest mechanistic breakthroughs for robust, reproducible results.
Bleomycin Sulfate (A8331): Technical Guide for Research Use
2026-04-12
Bleomycin Sulfate is a validated tool for inducing DNA strand breaks and modeling chemotherapy-related cellular injury or pulmonary fibrosis in research environments. This technical guide outlines actionable parameters and workflow best practices for in vitro and in vivo use. It should not be used outside experimental settings or for unvalidated indications.
SLC11A1 Activates TGF-β1 to Counteract Ferroptosis in Colore
2026-04-12
This study reveals that SLC11A1 promotes resistance to ferroptosis in colorectal cancer by activating the TGF-β1 signaling pathway. The findings highlight a mechanistic link relevant for tumor progression and offer a potential therapeutic target for colorectal cancer intervention.
EGTA (Egtazic Acid): Precision Calcium Chelation in Neuropro
2026-04-11
Harness the selectivity of EGTA for advanced calcium signaling pathway modulation and neuroprotection research. Discover optimized experimental workflows, troubleshooting strategies, and data-driven protocol parameters to drive reproducible results in apoptosis assays and neurodegenerative disease models.
RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy & C
2026-04-11
RapaLink-1, a third-generation mTOR inhibitor from APExBIO, enables reproducible induction of embryonic dormancy and robust inhibition of cancer cell growth, surpassing previous inhibitors in both potency and resistance management. This guide details actionable protocols and troubleshooting tips that accelerate research in both developmental biology and oncology.
Myriocin: Selective SPT Inhibitor for Sphingolipid Metabo...
2026-04-10
Myriocin is a potent, selective serine palmitoyltransferase (SPT) inhibitor used in sphingolipid metabolism and cancer research. It demonstrates nanomolar Ki, robust cell growth inhibition in lung cancer lines, and validated modulation of tumor suppressor pathways. Myriocin’s high purity and reproducibility make it a cornerstone reagent for oncology, immunology, and metabolic studies.
Balsalazide Disodium Dihydrate: Mechanistic Insight and S...
2026-04-09
This thought-leadership article provides an advanced, evidence-based exploration of Balsalazide Disodium Dihydrate as a water-soluble anti-inflammatory compound and 5-aminosalicylic acid (5-ASA) prodrug. Integrating cutting-edge radiotracer studies, mechanistic immunology, and practical guidance, we chart a new course for translational researchers seeking to harness targeted colonic activation, innovative imaging, and next-generation anti-inflammatory strategies in inflammatory bowel disease (IBD) and beyond.
Unlocking New Frontiers in Translational Oncology: Strate...
2026-04-08
This thought-leadership article presents an advanced synthesis of Sunitinib’s mechanistic actions and translational impact in cancer research. Integrating granular insight into RTK pathway inhibition, apoptosis induction, and anti-angiogenic mechanisms, we provide strategic guidance for preclinical and translational researchers. Drawing on landmark findings—such as the heightened sensitivity of ATRX-deficient tumors to RTK/PDGFR inhibition—we position Sunitinib (APExBIO) as a transformative research tool, moving beyond standard product listings and into the realm of visionary oncology research.
SP600125: Selective JNK Inhibitor for Advanced Cell Signa...
2026-04-08
Unlock precise modulation of JNK signaling with SP600125, a highly selective ATP-competitive JNK inhibitor trusted for apoptosis, inflammation, and neurodegeneration research. This guide details experimental workflows, troubleshooting strategies, and advanced applications, helping you achieve reproducible results and deeper mechanistic insight.
465 records 22/31 page Previous Next First page 上5页 2122232425 下5页 Last page